<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31517702</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>26</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1543-3641</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology</Title><ISOAbbreviation>Cogn Behav Neurol</ISOAbbreviation></Journal><ArticleTitle>Relationship Between Cognitive-Behavioral Impairment and Clinical and Functional Parameters in ALS and Reliability of the Edinburgh Cognitive and Behavioural ALS Screen to Assess ALS: Preliminary Findings.</ArticleTitle><Pagination><StartPage>185</StartPage><EndPage>192</EndPage><MedlinePgn>185-192</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/WNN.0000000000000199</ELocationID><Abstract><AbstractText Label="BACKGROUND">Although it is widely recognized that a high percentage of individuals with amyotrophic lateral sclerosis (ALS) have cognitive and behavioral impairment, the associated clinical and functional parameters remain unknown. ALS is typically assessed via screening tests, such as the Edinburgh Cognitive and Behavioural ALS Screen (ECAS).</AbstractText><AbstractText Label="OBJECTIVE">To investigate the relationship between cognitive-behavioral impairment and other clinical and functional parameters and to compare the assessment results from a set of standardized neuropsychological tests with those from the ECAS.</AbstractText><AbstractText Label="METHODS">Forty individuals with ALS participated in the study. We assessed attention, memory and learning ability, and executive function using a set of standardized neuropsychological tests and the ECAS. Sociodemographic variables, time since onset of symptoms, time since diagnosis, and functional respiratory values were recorded.</AbstractText><AbstractText Label="RESULTS">No relationship was found between time since onset of symptoms and time since definitive diagnosis and either attention (P=0.206, 0.314, respectively), memory and learning ability (P=0.618, 0.692), or executive function (P=0.844, 0.583). The set of standardized neuropsychological tests identified an impairment in executive function in 29% of the participants, whereas the ECAS identified it in 89%.</AbstractText><AbstractText Label="CONCLUSIONS">We found no relationship between cognitive-behavioral impairment and time since onset of symptoms nor time since ALS diagnosis. Because the ECAS does not correctly reflect the executive function of individuals with ALS, function-specific neuropsychological tests are preferred. Test selection must take into account individuals' physical characteristics and their consequent ability to respond gesturally or orally.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>D&#xed;az</LastName><ForeName>Jose Luis</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Respiratory Care Unit, Respiratory Medicine Department.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Airliquide Healthcare Group.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Health Research INCLIVA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mondrag&#xf3;n</LastName><ForeName>Helena</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Respiratory Care Unit, Respiratory Medicine Department.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Health Research INCLIVA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sancho</LastName><ForeName>Jes&#xfa;s</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Respiratory Care Unit, Respiratory Medicine Department.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Health Research INCLIVA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguilar</LastName><ForeName>Eduardo J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Institute of Health Research INCLIVA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University Hospital of Valencia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Servera</LastName><ForeName>Emilio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Respiratory Care Unit, Respiratory Medicine Department.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Health Research INCLIVA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Physiotherapy Department, University of Valencia, Valencia, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cogn Behav Neurol</MedlineTA><NlmUniqueID>101167278</NlmUniqueID><ISSNLinking>1543-3633</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="N">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31517702</ArticleId><ArticleId IdType="doi">10.1097/WNN.0000000000000199</ArticleId><ArticleId IdType="pii">00146965-201909000-00005</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>